EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H14BrN3O2S |
| Net Charge | 0 |
| Average Mass | 428.311 |
| Monoisotopic Mass | 426.99901 |
| SMILES | O=S(=O)(N=C1N=C2C=CC(Br)=CN2Cc2ccccc21)c1ccccc1 |
| InChI | InChI=1S/C19H14BrN3O2S/c20-15-10-11-18-21-19(22-26(24,25)16-7-2-1-3-8-16)17-9-5-4-6-14(17)12-23(18)13-15/h1-11,13H,12H2 |
| InChIKey | AUPBGTHXQXUXTF-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-(2-bromo-11H-pyrido[1,2-b][2,4]benzodiazepin-6-ylidene)benzenesulfonamide (CHEBI:105860) is a benzodiazepine (CHEBI:22720) |
| Manual Xrefs | Databases |
|---|---|
| LSM-17221 | LINCS |